To advance urologic care through computational and functional genomics:
– Deciphering mechanisms of response and resistance to therapy
– Establishing new models to define gene function and cell phenotypes
– Fostering a new generation of computational urologists
We are looking forward to growing our lab and community. If you want to learn more about our work, please reach out to us!
01.24.2024 Kate selected to present her single cell work at American Association for Cancer Research (AACR) Annual Meeting
01.19.2024 Filipe is the 2023 awardee of the BCAN Bladder Cancer Career Development Award
12.19.2023 Chris’s work selected for presentation at European Association of Urology Annual meeting in Paris
11.06.2023 Filipe promoted to Assistant Professor of Surgery, Harvard Medical School
05.31.2023 Konrad’s work presented at ASCO Annual Meeting
04.20.2023 Welcome Kate!
Continuing on the Boston @harvardmed @DanaFarber_GU theme (I'm not biased or anything...), @CharleneMantia will elaborate on Neoadjuvant and Adjyuvant therapies for advanced #bladdercancer!
We're not done with Filipe! We're bringing home another Hoya Urologist! I can't wait to see @egan_jillian26 @AlbanyMedUro and hear her talk on trimodal therapy for #BladderCancer! @BWHUrology @MGHUrology
Welcoming back one of our own! So excited to welcome @CarvalhoFilipeL @BWHUrology @harvardmed home to explore the world of new #BladderCancer options for BCG-resistent disease.